Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone

Por Cavalli-Björkman, N, Qvortrup, C, Sebjørnsen, S, Pfeiffer, P, Wentzel-Larsen, T, Glimelius, B, Sorbye, H
Publicado em 2012

Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer

Por Glimelius, B, Garmo, H, Berglund, Å, Fredriksson, L A, Berglund, M, Kohnke, H, Byström, P, Sørbye, H, Wadelius, M
Publicado em 2011

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study

Por Roy, A, Cunningham, D, Hawkins, R, Sörbye, H, Adenis, A, Barcelo, J-R, Lopez-Vivanco, G, Adler, G, Canon, J-L, Lofts, F, Castanon, C, Fonseca, E, Rixe, O, Aparicio, J, Cassinello, J, Nicolson, M, Mousseau, M, Schalhorn, A, D'Hondt, L, Kerger, J, Hossfeld, D K, Garcia Giron, C, Rodriguez, R, Schoffski, P, Misset, J-L
Publicado em 2012